| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790084 | Urologic Oncology: Seminars and Original Investigations | 2018 | 13 Pages |
Abstract
We propose that targeting the autophagic machinery might represent a suitable approach to complement or even increase cisplatin efficacy in order to overcome cisplatin resistance in urothelial carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
David M.Sc., Margaretha A. M.Sc., Niklas M.Sc., Philip M.Sc., Jana M.Sc., Fabian M.Sc., Nora Ph.D., Wenxian M.Sc., Christoph Ph.D., Michèle J. Ph.D., Günter M.D., Björn Ph.D.,